Instituto de Diagnostico SA
SGO:INDISA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 199.3
1 626.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CLP.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Instituto de Diagnostico SA
|
Revenue
|
230.6B
CLP
|
|
Cost of Revenue
|
-176.6B
CLP
|
|
Gross Profit
|
54B
CLP
|
|
Operating Expenses
|
-42.4B
CLP
|
|
Operating Income
|
11.6B
CLP
|
|
Other Expenses
|
-6.2B
CLP
|
|
Net Income
|
5.4B
CLP
|
Income Statement
Instituto de Diagnostico SA
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
188 543
N/A
|
190 227
+1%
|
192 568
+1%
|
191 914
0%
|
191 288
0%
|
193 826
+1%
|
200 653
+4%
|
208 743
+4%
|
218 934
+5%
|
225 627
+3%
|
230 638
+2%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(137 858)
|
(139 194)
|
(140 900)
|
(143 447)
|
(145 783)
|
(154 053)
|
(161 414)
|
(167 504)
|
(174 046)
|
(175 297)
|
(176 632)
|
|
| Gross Profit |
50 686
N/A
|
51 033
+1%
|
51 669
+1%
|
48 467
-6%
|
45 505
-6%
|
39 773
-13%
|
39 239
-1%
|
41 239
+5%
|
44 887
+9%
|
50 329
+12%
|
54 006
+7%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(28 316)
|
(28 686)
|
(29 709)
|
(29 839)
|
(32 194)
|
(34 251)
|
(37 732)
|
(40 570)
|
(41 092)
|
(42 041)
|
(42 424)
|
|
| Selling, General & Administrative |
(27 183)
|
(27 684)
|
(28 778)
|
(28 976)
|
(31 516)
|
(33 543)
|
(36 830)
|
(39 663)
|
(39 611)
|
(40 424)
|
(40 657)
|
|
| Depreciation & Amortization |
(1 052)
|
(986)
|
(1 015)
|
(1 100)
|
(1 039)
|
(1 097)
|
(1 128)
|
(1 110)
|
(1 077)
|
(1 016)
|
(967)
|
|
| Other Operating Expenses |
(81)
|
(15)
|
84
|
237
|
362
|
389
|
225
|
203
|
(404)
|
(601)
|
(800)
|
|
| Operating Income |
22 369
N/A
|
22 347
0%
|
21 960
-2%
|
18 628
-15%
|
13 312
-29%
|
5 521
-59%
|
1 506
-73%
|
669
-56%
|
3 796
+467%
|
8 288
+118%
|
11 583
+40%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
2 144
|
3 055
|
2 277
|
1 182
|
(889)
|
(3 568)
|
(4 852)
|
(6 142)
|
(6 591)
|
(6 476)
|
(6 135)
|
|
| Total Other Income |
(136)
|
(145)
|
153
|
182
|
230
|
292
|
229
|
184
|
214
|
205
|
(35)
|
|
| Pre-Tax Income |
24 378
N/A
|
25 257
+4%
|
24 389
-3%
|
19 992
-18%
|
12 652
-37%
|
2 245
-82%
|
(3 116)
N/A
|
(5 289)
-70%
|
(2 581)
+51%
|
2 017
N/A
|
5 413
+168%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(3 728)
|
(3 407)
|
(2 584)
|
(1 125)
|
398
|
2 413
|
3 767
|
3 535
|
2 725
|
1 443
|
(40)
|
|
| Income from Continuing Operations |
20 650
|
21 850
|
21 805
|
18 867
|
13 050
|
4 658
|
651
|
(1 754)
|
144
|
3 460
|
5 373
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
20 650
N/A
|
21 850
+6%
|
21 805
0%
|
18 867
-13%
|
13 050
-31%
|
4 658
-64%
|
651
-86%
|
(1 754)
N/A
|
144
N/A
|
3 460
+2 298%
|
5 373
+55%
|
|
| EPS (Diluted) |
146.45
N/A
|
155.04
+6%
|
154.72
0%
|
133.87
-13%
|
92.6
-31%
|
33.05
-64%
|
4.62
-86%
|
-12.44
N/A
|
1.02
N/A
|
24.55
+2 307%
|
38.13
+55%
|
|
You don't have any saved screeners yet
